7th Annual FIMSA Congress 2018

November 10-13, 2018 | Mandarin Hotel Bangkok, Bangkok, Thailand

Event

Reveal immune signatures in higher dimension.

Immune cell responses to cancer, infection or self are dynamic and complex. Translational studies, where cell and tumor samples are often limited in size and availability, pose a particular challenge when studying the complexity of immune response. Using higher-dimensional analyses, researchers are describing novel immune cell subsets with previously unrecognized functionalities at an ever-increasing rate.

At Fluidigm, we’re committed to providing you with the tools you need to explore immune responses from every angle—revealing new insights and identifying novel immune signatures in both health and disease.

Product Presentations

Comprehensive end-to-end workflows from Fluidigm allow you to interrogate complex immune cell populations from every angle.

Visit us to learn more.

Exhibit Information
November 10-13, 2018
9:00 am-5:00 pm
Mandarin Hotel Bangkok
662 Rama IV Road, Bang Rak
Bangkok, 10500 Thailand

Biomark HD

Reveal gene expression signatures of tumor immune response using the Biomark HD.

 

Biomark HD

C1™
Reveal the diversity of immune cell subpopulations and T cell receptor clonotypes in health and disease states at single cell resolution.

C1

Juno
Juno™ provides the industry’s most scalable, customizable and cost-efficient library prep workflow for targeted NGS.

Juno

Advanta reagent portfolio
Advanta™ assays, panels and kits offer a growing menu of pre-designed, optimized reagents for genomic analysis.

  • Advanta IO Gene Expression Assay
  • Advanta FFPE RNA Extraction Kit
  • Advanta Sample ID Genotyping Panel
Advanta kit

Powering Multi-omic Translational Studies with Mass Cytometry

Tuesday, November 13
12:00-12:30 pm
Mandarin Room B
Mandarin Hotel Bangkok

Mass cytometry is a powerful research tool for elucidating the mechanisms underlying human disease and assessing treatment efficacy. Enabling high-parameter studies through modular panel design, mass cytometry has quickly become a mainstay at multiple immune monitoring core facilities and translational research laboratories around the world.

In this presentation, Oliver Vasilevski, PhD, Fluidigm, will discuss:

  • Basic principles of mass cytometry (CyTOF® technology).
  • Use of the technology in both low-plex (15–25 parameters) and high plex (>30 parameters) research studies.
  • Application examples for immune profiling as well as intracellular cytokine and signaling protein analysis.

Register your interest to attend.




For Research Use Only. Not for use in diagnostic procedures.